Since the growth and metastasis of most primary tumors depend on the overexpression of vascular endothelial growth factor receptor-1 (VEGFR-1) as a crucial protein, VEGFR-1 can be considered a suitable target for the development of tumor-targeted CPPs [90]. The gene discussed is FLT1; the disease is neoplasm.